VIROPHARMA INC's ticker is and the CUSIP is 928241AH1. A total of 29 filers reported holding VIROPHARMA INC in Q3 2013. The put-call ratio across all filers is - and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2013 | $12,869,000,000 | – | 6,000,000 | – | 0.27% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sage Capital Management, LLC | 3,300,000 | $7,072,000 | 6.75% |
| SYMPHONY ASSET MANAGEMENT LLC | 23,200,000 | $49,721,000 | 5.04% |
| Mohican Financial Management, LLC | 10,259,000 | $21,986,000 | 5.01% |
| GRACE BROTHERS MANAGEMENT LLC | 2,500,000 | $5,361,000 | 4.56% |
| BASSO CAPITAL MANAGEMENT, L.P. | 8,750,000 | $18,714,000 | 3.27% |
| Bruce & Co., Inc. | 2,000,000 | $4,000,000 | 1.31% |
| TENOR CAPITAL MANAGEMENT Co., L.P. | 6,000,000 | $12,872,000 | 1.22% |
| Verition Fund Management LLC | 2,500,000 | $5,370,000 | 0.81% |
| Polar Asset Management Partners Inc. | 7,500,000 | $16,078,000 | 0.68% |
| WOLVERINE ASSET MANAGEMENT LLC | 12,955,000 | $27,745,000 | 0.62% |